Business Context and Reporting Period
Company: Harvard Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Report Date: August 4, 2011
Reporting Period: The filing announces financial results for the three and six months ended June 30, 2011.
Key Financial Metrics
The provided text serves as a cover report referencing a press release (Exhibit 99.1) for detailed data. The filing text itself does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The filing text does not contain specific comparative data or descriptions of material changes versus prior periods. Investors must refer to the incorporated press release for this information.
Guidance, Outlook, and Risks
Management Commentary: The Company issued a press release on August 4, 2011, regarding the reported period.
Legal Disclaimer: The information in Item 2.02 and the attached press release is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section, nor is it incorporated by reference in other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for the periods ended June 30, 2011.
- Verify year-over-year and quarter-over-quarter performance trends not detailed in this summary.
- Confirm any forward-looking statements or guidance provided in the referenced press release.
- Note that the financial data in this 8-K is not legally "filed" for liability purposes under Section 18 of the Exchange Act.